Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

XOMA Corporation (XOMA)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

Market reaction Comment Full text

Instil Bio Inc (TIL)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL

Market reaction Comment Full text

Teleflex Incorporated (TFX)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX

Market reaction Comment Full text

Ultragenyx Pharmaceutical Inc (RARE)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE

Market reaction Comment Full text

Vanda Pharmaceuticals Inc (VNDA)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA

Market reaction Comment Full text

Aquestive Therapeutics Inc (AQST)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST

Market reaction Comment Full text

Air Products and Chemicals Inc (APD)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 0
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products and Chemicals, Inc. - APD

Market reaction Comment Full text

Corcept Therapeutics Incorporated (CORT)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT

Market reaction Comment Full text

Rezolute Inc. (RZLT)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 0
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT

Market reaction Comment Full text

Organogenesis Holdings Inc. (ORGO)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

Market reaction Comment Full text

agilon health Inc (AGL)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL

Market reaction Comment Full text

Nektar Therapeutics (NKTR)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

Market reaction Comment Full text

Mereo BioPharma (MREO)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

Market reaction Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 1
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Integer Holdings Corporation of Class Action Lawsuit and Upcoming Deadlines - ITGR

Market reaction Comment Full text

Galectin Therapeutics Inc. (GALT)

  • Business News
  • Jan. 22, 2026, 15:00 UTC
  • 0
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT

Market reaction Comment Full text
  • Previous
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next

Search

News categories

  • Technical Exchange News(10841)
  • Event(2204)
  • SEC News(187799)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124251)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin